U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146672) titled 'Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors' on Aug. 21.
Brief Summary: The study is a controlled, open-label exploratory clinical trial.
Study Start Date: July 31
Study Type: INTERVENTIONAL
Condition:
Solid Tumor Cancer
Intervention:
BIOLOGICAL: Super DC Vaccine
Super DC Cell Injection
Recruitment Status: RECRUITING
Sponsor: Shanghai Cell Therapy Group Co.,Ltd
Published by HT Digital Content Services with permission from Health Daily Digest....